Log In
BCIQ
Print this Print this
 

Lisuride hydrogen maleate

  Manage Alerts
Collapse Summary General Information
Company Sinoxa Pharma UG
DescriptionSerotonin (5-HT2B) receptor blocker
Molecular Target Serotonin (5-HT2B) receptor
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationHypertension
Indication DetailsTreat pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH)
Regulatory Designation EU - Orphan Drug (Treat pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH))
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today